Prevalence and differentiation of hereditary breast and ovarian cancers in Japan-Reference-Cited by-同舟云学术

Prevalence and differentiation of hereditary breast and ovarian cancers in Japan

Published:2013-11-19 Issue:5 Volume:22 Page:462-468
ISSN:1340-6868
Container-title:Breast Cancer
language:en
Short-container-title:Breast Cancer

Author:

Nakamura Seigo,Takahashi Masato,Tozaki Mitsuhiro,Nakayama Takahiro,Nomizu Tadashi,Miki Yoshio,Murakami Yoshie,Aoki Daisuke,Iwase Takuji,Nishimura Seiichiro,Yamauchi Hideko,Ohsumi Shozo,Baba Shinichi,Shimizu Tadao

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12282-013-0503-1.pdf

Reference27 articles.

1. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66–71.

2. Risch HA, McLaughlin JR, Cole DE, et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet. 2001;68:700–10.

3. Risch HA, McLaughlin JR, Cole DE, et al. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst. 2006;98:1694–706.

4. Loman N, Johannsson O, Kristoffersson U, et al. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst. 2001;93:1215–23.

5. Ikeda N, Miyoshi Y, Yoneda K, et al. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families. Int J Cancer. 2001;91:83–8.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status and future perspectives of contrast-enhanced ultrasound diagnosis of breast lesions;Journal of Medical Ultrasonics;2024-08-23

2. Development of a novel prediction model for carriage of BRCA1/2 pathogenic variant in Japanese patients with breast cancer based on Japanese Organization of Hereditary Breast and Ovarian Cancer registry data;2024-06-11

3. Acquired Treatment Resistance in a Patient with Metastatic PD-L1-Positive Breast Cancer and Germline BRCA1 Mutation;Case Reports in Oncology;2023-07-14

4. Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers;Journal of Medical Ultrasonics;2023-03-11

5. Registration Data of Japanese Organization of Hereditary Breast and Ovarian Cancer Till 2020;Practical Guide to Hereditary Breast and Ovarian Cancer;2023